tiprankstipranks
Zelira Therapeutics (AU:ZLD)
ASX:ZLD
Australian Market

Zelira Therapeutics (ZLD) Income Statement

Compare
5 Followers

Zelira Therapeutics Income Statement

Last quarter (Q4 2024), Zelira Therapeutics's total revenue was AU$40.23K, a decrease of -95.05% from the same quarter last year. In Q4, Zelira Therapeutics's net income was AU$-2.43M. See Zelira Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 24Jun 23Jun 22Jun 21Jun 20
Total Revenue
AU$ 94.95KAU$ 301.12KAU$ 1.54MAU$ 663.32KAU$ 0.00
Gross Profit
AU$ 10.28KAU$ -3.22MAU$ -5.72MAU$ -39.16KAU$ -275.05K
Operating Expenses
AU$ 5.95MAU$ 4.20MAU$ 7.70MAU$ 9.61MAU$ 7.56M
Depreciation and Amortization
AU$ 479.04KAU$ 545.22KAU$ 588.54KAU$ 474.25KAU$ 275.05K
EBITDA
AU$ -36.44MAU$ -6.87MAU$ -12.83MAU$ -9.18MAU$ -7.71M
Operating Income
AU$ -5.94MAU$ -7.41MAU$ -13.41MAU$ -9.65MAU$ -7.84M
Other Income/Expenses
AU$ -31.72MAU$ -148.40KAU$ -290.82KAU$ -275.31KAU$ 725.95K
Pretax Income
AU$ -37.66MAU$ -7.41MAU$ -13.71MAU$ -9.93MAU$ -8.00M
Net Income
AU$ -36.57MAU$ -5.57MAU$ -11.95MAU$ -8.55MAU$ -7.02M
Per Share Metrics
AU$ ―AU$ ―AU$ ―AU$ ―AU$ ―
Basic EPS
AU$ -3.22AU$ -0.55AU$ -1.49AU$ -1.29AU$ -1.45
Diluted EPS
AU$ -3.22AU$ -0.55AU$ -1.49AU$ -1.29AU$ -1.45
Weighted Average Shares Outstanding
11.35M 10.07M 8.04M 6.63M 4.85M
Weighted Average Shares Outstanding (Diluted)
11.35M 10.07M 8.04M 6.63M 4.85M
Currency in AUD

Zelira Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis